Back to Resource Center

Evofem Biosciences announces positive top-line results of phase 3 study evaluating Amphora for hormone-free birth control

Evofem Biosciences announces positive top-line results of phase 3 study evaluating Amphora for hormone-free birth control

December 2018

Click to view Press Release

Click for full info +

Full Info:


Resource Type:

Press Release

Citation:

(2018, December 17). Evofem Biosciences.

Health Risks(s):

  • STI / STD
  • Unintended Pregnancy

Product type(s):

  • Contraceptives
  • Hormonal
  • MPTs
  • VaginalCream

Topic(s):

  • MPTs
  • Development

      URL of resource:

      https://evofem.investorroom.com/2018-12-17-Evofem-Biosciences-Announces-Positive-Top-Line-Results-of-Phase-3-Study-Evaluating-Amphora-for-Hormone-Free-Birth-Control

      Back to Resource Center